Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics

KPTI POWR Grades

• Growth is the dimension where KPTI ranks best; there it ranks ahead of 92.59% of US stocks.
• The strongest trend for KPTI is in Value, which has been heading up over the past 179 days.
• KPTI ranks lowest in Stability; there it ranks in the 0th percentile.

KPTI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for KPTI is -2.63 -- better than merely 2.98% of US stocks.
• KPTI's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 3.14% of US stocks.
• Revenue growth over the past 12 months for Karyopharm Therapeutics Inc comes in at 94.12%, a number that bests 91.35% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Karyopharm Therapeutics Inc, a group of peers worth examining would be BYSI, INSM, ALBO, INFN, and RDUS.
• Visit KPTI's SEC page to see the company's official filings. To visit the company's web site, go to www.karyopharm.com.

KPTI Valuation Summary

• In comparison to the median Healthcare stock, KPTI's EV/EBIT ratio is 108.87% lower, now standing at -2.6.
• KPTI's EV/EBIT ratio has moved up 18.3 over the prior 95 months.
• Over the past 95 months, KPTI's price/sales ratio has gone down 1018.6.

Below are key valuation metrics over time for KPTI.

KPTI Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -56.38%.
• Its year over year net income to common stockholders growth rate is now at -7.72%.
• Its 5 year net cashflow from operations growth rate is now at -74.5%.

KPTI's revenue has moved up $209,701,000 over the prior 52 months.

The table below shows KPTI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	209.819	-107.116	-124.088
2021-09-30	118.65	-163.225	-206.229
2021-06-30	102.294	-183.582	-207.912
2021-03-31	113.207	-168.111	-200.756
2020-12-31	108.085	-160.234	-196.273
2020-09-30	91.081	-169.089	-201.499

KPTI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• KPTI has a Quality Grade of C, ranking ahead of 58.11% of graded US stocks.
• KPTI's asset turnover comes in at 0.338 -- ranking 138th of 681 Pharmaceutical Products stocks.
• CAPR, DRNA, and PLXP are the stocks whose asset turnover ratios are most correlated with KPTI.

The table below shows KPTI's key quality metrics over time.